secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2023-08-25T23:59:59+00:00
Accession:  0001104659-23-095325
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma gets Nasdaq notice for bid price below $1 for 30 days
--------------------------------------------------------------------------

- Nasdaq notified First Wave BioPharma on Aug. 24, 2023 of non-compliance with Listing Rule 5550(a)(2).
- Company has 180 days, until Feb. 20, 2024, to regain compliance by closing at $1.00 for 10+ consecutive days.
- No immediate effect on listing; company may qualify for a second 180-day period if it meets other listing standards.
- Failure to cure could lead to delisting, subject to appeal to a Nasdaq hearings panel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923095325/0001104659-23-095325-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923095325/tm2324766d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-095325

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer